Good News | Honoring the Journey!Seriesth Bio Wins Second Prize in the "Entrepreneurship Yongkang·2025 Innovation and Entrepreneurship Competition"

2026-03-25

On March 20, the "Entrepreneurship Yongkang·2025 Innovation and Entrepreneurship Competition" concluded successfully. After three months of rigorous selection and fierce competition, Sirimei Bio, a subsidiary of Xingyue Bio, secured the second prize (third place overall) with its project "Key Preparation Technology Development and Industrialization of Silk-Based Materials in the Field of Skin Regeneration and Repair." A total of 283 projects participated in the competition, with 16 advancing to the finals. The awards included one first prize, three second prizes, five third prizes, and seven excellence awards.

null


The competition, themed "Forging the Future through Innovation," focused on strategic emerging industries such as modern hardware, high-end equipment, new materials, and biomedicine. It aimed to establish a platform for gathering high-quality resources and promoting the deep integration of technological innovation with industrial innovation, attracting outstanding innovation and entrepreneurship projects from across the country. The event was not only a showcase of innovation and entrepreneurial achievements but also a practical initiative by Yongkang to foster the deep integration of innovation chains, industrial chains, capital chains, and talent chains.

null


As a local technological enterprise in Yongkang, Seriesth Bio participated with its core technological project. Aligned with cutting-edge fields in the health industry, the project leverages the excellent biocompatibility, mechanical properties, and degradability of silk fibroin to focus on the field of skin regeneration and repair. The company has successfully developed a series of medical-grade raw materials and wound repair devices. Currently, Seriesth Bio has established a standardized production line in Yongkang, including a self-built, over 10,000-square-meter, fully automated, sterile, and digitalized cleanroom facility (Class 10,000). This has enabled the large-scale implementation of its technological achievements, facilitating the innovative transition of silk fibroin from traditional textiles to the healthcare sector. The company provides safe and efficient advanced solutions for skin wound repair, demonstrating its strong R&D capabilities and innovative vitality in the biomaterials field. This project also serves as a microcosm of how local technological enterprises in Yongkang are focusing on niche sectors to drive the translation of research outcomes into practical applications.

null


This award not only highlights the company's technological breakthroughs in the field of silk-based biomaterials but also aligns with the competition's core goals of fostering industrial connections and commercializing results. The company's project deeply resonates with Yongkang's strategic direction of cultivating emerging industries and promoting industrial transformation and upgrading, earning high recognition from the judging panel of experts.

null


In the future, the company will leverage this achievement, fully supported by Yongkang's favorable innovation and entrepreneurship ecosystem and supportive policies, to continue increasing investment in R&D. It aims to accelerate the industrialization of the award-winning project, further expand the application scenarios of silk fibroin protein in areas such as medical treatment, medical aesthetics, and skincare, promote the innovative development of high-end domestic biomaterials, and contribute to Yongkang's efforts to build a regional innovation brand and cultivate new productive forces.

Search

  • Official account